Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 28, 2012; 18(28): 3732-3737
Published online Jul 28, 2012. doi: 10.3748/wjg.v18.i28.3732
Table 1 Patient baseline characteristics (n = 48) n (%)
Overall(n = 48)GEJ obstruction(n = 18)Non-GEJ obstruction(n = 30)P value
Age (yr, mean ± SD)68.4 ± 10.565.8 ± 10.369 ± 10.50.749
Male39 (81.3)12 (25.0)27 (56.2)0.045
Histological diagnosis
Squamous cell carcinoma32 (66.6)2300.001
Adenocarcinoma16 (33.4)1600.001
Type of treatment before SEMS placement
Supportive care29 (60.4)10190.594
Chemotherapy11 (22.9)740.041
Radiation therapy7 (14.6)160.170
Chemoradiation therapy1 (2.1)010.434
Table 2 Clinical outcomes in 48 patients n (%)
OutcomesOverall(n = 48)GEJ obstruction(n = 18)Non-GEJ obstruction(n = 30)
Technical success48 (100)18 (100)30 (100)
Clinical success48 (100)18 (100)30 (100)
Mean dysphagia score preprocedure (mean ± SD)3.20 ± 0.683.05 ± 0.633.30 ± 0.70
Mean dysphagia score postprocedure (mean ± SD)1.77 ± 0.771.77 ± 0.731.76 ± 0.81
Change dysphagia score (paired-t test) (P value)< 0.001< 0.001< 0.001
Table 3 Complications and causes of stent malfunctions n (%)
Overall(n = 48)GEJ obstruction(n = 18)Non-GEJ obstruction(n = 30)P value
Causes of stent malfunctions
Overgrowth13 (27.1)5 (27.8)8 (26.7)0.933
Migration1 (2.1)1 (5.6)0 (0.0)0.192
Food impaction2 (4.2)1 (5.6)1 (3.3)0.709
Other complications
Reflux esophagitis13 (27.1)8 (44.4)5 (16.7)0.036
Aspiration pneumonia5 (10.4)0 (0.0)5 (16.7)0.06
Fistula2 (4.2)0 (0.0)2 (6.7)0.263